Joint ENGOT and GOG Foundation requirements for trials with industry partners

Ignace Vergote; Robert L Coleman; Sandro Pignata; Michael A Bookman; Christian Marth; Thomas J Herzog; Antonio Gonzalez Martin; Larry J Copeland

doi:10.1136/ijgc-2019-000441

Article info

other Versions

You are currently viewing an earlier version of this article (September 01, 2019).
View the most recent version of this article

PDF

Original Article

Joint ENGOT and GOG Foundation requirements for trials with industry partners

Free

Authors

Ignace Vergote ENGOT/BGOG and University Hospital Leuven, Gynaecological Oncology Leuven Cancer Institute, Leuven, Belgium, European Union PubMed articles Google scholar articles
Robert L Coleman GOG-F and Gynecologic Oncology & Reproductive Medicine, University of Texas; M.D. Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Sandro Pignata ENGOT/MITO Gynaecological Oncology, National Cancer Institute Napels, Naples, Italy PubMed articles Google scholar articles
Michael A Bookman GOG-F and Gynecologic Oncology Therapeutics, Kaiser Permanente San Francisco, San Francisco, California, USA PubMed articles Google scholar articles
Christian Marth ENGOT/A-AGO and Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria PubMed articles Google scholar articles
Thomas J Herzog GOG-F and Gynecologic Oncology, University of Cincinnati, Cincinnati, Ohio, USA PubMed articles Google scholar articles
Antonio Gonzalez Martin ENGOT/GEICO and Medical Oncology, Clinica Universidad de Navarra, Madrid, Spain PubMed articles Google scholar articles
Larry J Copeland GOG-F and Gynecologic Oncology, Ohio State University Wexner Medical Center and JamesCare Gynecologic Oncology at Mill Run, Columbus, Ohio, USA PubMed articles Google scholar articles
On behalf of The European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc
Google scholar articles

Correspondence to Professor Ignace Vergote, Gynaecological Oncology, Universitaire Ziekenhuizen Leuven, Leuven, Vlaams Brabant, Belgium-European Union; ignace.vergote{at}uz.kuleuven.ac.be

Citation

Vergote I, Coleman RL, Pignata S On behalf of The European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc, et al

Joint ENGOT and GOG Foundation requirements for trials with industry partners

International Journal of Gynecologic Cancer Published Online First: 18 July 2019. doi: 10.1136/ijgc-2019-000441

Publication history

Received April 24, 2019
Accepted April 26, 2019
First published July 18, 2019.

Article Versions

You are currently viewing a Previous version of this article (1 September 2019).
View the most recent version of this article

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password